Jena

Germany

322 total trials 149 recruiting

Filter these 322 trials by phase, condition, sponsor and more.

Open in Search →

A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Su … Ended

2023-506687-13-00 5 2019-01-31 Primary Generalized Tonic-Clonic Seizures
A study of Chemo only versus Chemo plus Nivo with or without BMS986205, Followed by Post- Surgery Therapy with Nivo or Nivo and BMS986205 in … Ended

2024-512158-12-00 5 2018-12-14 Bladder Cancer Muscle-Invasive Bladder Cancer
A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Cabozantinib versus Sunitinib in Participants with Previously Untreated, … Ended

2023-509711-83-00 5 2017-10-27 Advanced or Metastatic Renal Cell Carcinoma
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3 … Ended

2022-501251-81-00 5 2017-06-08 Renal cell carcinoma
CheckMate 901: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 901 Ended

2022-501784-40-00 5 2017-05-26 Untreated Unresectable or Metastatic Urothelial Cancer
Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of … Ended

2024-512934-14-00 5 2016-11-07 advanced or metastatic adenocarcinoma of the stomach or gastroesophage
HD21 Ended

2024-518022-33-00 5 2016-07-15 Advanced Stage of Hodgkin Lymphoma
A Phase 3 Study of Nivolumab plus Ipilimumab Versus Sunitinib in untreated Subjects with Advanced or Metastatic Renal Cell Carcinoma (RCC) Ended

2023-504761-23-00 5 2014-11-19 Advanced or metastatic renal cell carcinoma
Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem … Ended

2022-502040-13-00 4 High-risk Myelodysplastic neoplasia
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart i … Ended

2024-512986-15-00 4 Sjögren’s Disease

Showing 313–322 of 322 trials